Theras best company under 40 - Industria Felix


Theras best company under 40 - Industria Felix

Theras best company under 40 - Industria Felix

The winners of the 5th edition of the Felix Award will be announced today

Theras Lifetech, research leader and best company under 40,

wins the Industria Felix 2021 Award

Among the leading Italian companies, unique player in the pharmaceutical sector in Emilia Romagna, Theras Lifetech based in Salsomaggiore, making devices for the management of diabetes and chronic pain, will collect the Prize in virtual mode


Salsomaggiore Terme 8 April 2021 - A challenge successfully passed for the fourth consecutive year for Theras Lifetech. Incorporated in the province of Parma, Theras Lifetech has now been awarded the  Industria Felix Award 2021 as the best under 40 company for business performance and financial reliability.

A well-deserved achievement, the outcome of surprising results in the research and marketing of cutting-edge technologies for the treatment and continuous monitoring of diabetes and the management of chronic pain.


The award, sponsored by Industria Felix Magazine (the Sole 24 Ore quarterly Economics and Finance supplement in collaboration with the Centro Studi Economici of Cerved, the 'Luiss Guido Carli University and Associazione culturale Industria Felix), goes to national businesses who set the example of growth and business excellence and contribute to top quality business management, job creation, social welfare and economic progress.


"I would like to thank Industria Felix for this important recognition coming at the end of a very challenging year, with many companies like ours, committed to providing innovative solutions at such a complex time - says Federico FERRARI, Chief Operating Officer of Theras Lifetech - It is a strong encouragement to continue a growth strategy based on solid ethical principles. Led by passion, we aim at perfecting more and more advanced services and products for a better management of chronic diseases such as diabetes and neuropathic pain".

Theras Lifetech closed 2020 with a turnover of almost 84 million euro with a 40% increase over the 60 million euro of the previous year. The staff is made up of about 100 people including employees and external collaborators. Half of them are engaged throughout the country to provide technical support to health facilities, doctors and patients, with an assistance service active 24 hours a day, 7 days a week.

Theras Lifetech boasts commercial partnerships with sector-leading American companies. These are Dexcom and Insulet (which Forbes ranks second and fourth among innovative companies with the highest growth) and Nevro, an American company that has patented an exclusive therapy for the treatment of chronic pain. Furthermore, Theras Lifetech collaborates with over 200 hospitals and specialist clinics throughout Italy.


Related news

Life Science Innovation: the ecosystem that brings change

The first workshop of the new Observatory dedicated to Life Science Innovation

Read more

Theras among Italy's top 50 companies as Champions of Growth 2022

Double recognition for Theras Lifetech and Theras Biocare as leaders in technology and innovation

Read more

The most beautiful emotions must be lived without interruptions

Theras tells how and how much technology improves the quality of life for people with chronic diseases.

Read more